Benitec Biopharma Inc.
BNTC
$11.50
-$0.18-1.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.84M | -8.97M | -16.15M | -9.35M | -9.55M |
| Total Depreciation and Amortization | 120.00K | 118.00K | 118.00K | 106.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.38M | 5.18M | 13.45M | 2.60M | 2.37M |
| Change in Net Operating Assets | 562.00K | 316.00K | -5.64M | 3.57M | -606.00K |
| Cash from Operations | -3.78M | -3.35M | -8.21M | -3.09M | -7.70M |
| Capital Expenditure | -11.00K | -- | 0.00 | -6.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.00K | -- | 0.00 | -6.00K | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 104.50M | -- | 42.35M | -- | 17.87M |
| Repurchase of Common Stock | -- | -- | -- | -9.07M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.27M | -- | -39.80M | 37.48M | -2.00K |
| Cash from Financing | 98.23M | -- | 2.54M | 28.41M | 17.87M |
| Foreign Exchange rate Adjustments | -132.00K | 86.00K | -120.00K | -21.00K | 285.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.31M | -3.27M | -5.79M | 25.30M | 10.44M |